Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis

By Lasco A.   Catalano A.   Morabito N.   Gaudio A.   Basile G.   Trifiletti A.   Atteritano M.  

Osteoporosis International, Vol. 22, Iss. 1, 2011-01 ,pp. : 299-303

Springer Publishing Company

Access to resources Recommend Favorite

Postmenopausal women with osteoporosis: experience when treated with teriparatide in clinical practice

By Ish-Shalom Sophia   Dumitrache Constantin   El-Husseini Timour Fikry   Hussein Azza   Barker Clare   Pavo Imre  

Current Medical Research and Opinion, Vol. 27, Iss. 2, 2011-02 ,pp. : 343-353

Informa Healthcare

Access to resources Recommend Favorite

Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment

By Miller P.   Schwartz E.   Chen P.   Misurski D.   Krege J.  

Osteoporosis International, Vol. 18, Iss. 1, 2007-01 ,pp. : 59-68

Springer Publishing Company

Access to resources Recommend Favorite

A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6-month study

By Kung A. W. C.   Pasion E. G.   Sofiyan M.   Lau E. M. C.   Tay B. K.   Lam K. S.   Wilawan K.   Ongphiphadhanakul B.   Thiebaud D.  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 929-937

Informa Healthcare

Access to resources Recommend Favorite

Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis

By Macdonald H.   Nishiyama K.   Hanley D.   Boyd S.  

Osteoporosis International, Vol. 22, Iss. 1, 2011-01 ,pp. : 357-362

Springer Publishing Company

Access to resources Recommend Favorite